The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cell Therapy Technologies-Global Market Insights and Sales Trends 2024

Cell Therapy Technologies-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1836309

No of Pages : 102

Ask Your Query

Synopsis

The global Cell Therapy Technologies market size is expected to reach US$ 17610 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Therapy Technologies in various end use industries.

The expanding demands from the Human and Animal, are propelling Cell Therapy Technologies market. Equipment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Consumables segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Therapy Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cell Therapy Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cell Therapy Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Therapy Technologies sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Cell Therapy Technologies covered in this report include Danaher, Thermo Fisher Scientific, Merck, Terumo, BD, Lonza Group, GE Healthcare, Sartorius and Stemcell Technologies, etc.

The global Cell Therapy Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Danaher
  • Thermo Fisher Scientific
  • Merck
  • Terumo
  • BD
  • Lonza Group
  • GE Healthcare
  • Sartorius
  • Stemcell Technologies
  • Miltenyi Biotec

Global Cell Therapy Technologies market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Cell Therapy Technologies market, Segment by Type:

  • Equipment
  • Consumables
  • Others

Global Cell Therapy Technologies market, by Application

  • Human
  • Animal

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Therapy Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Cell Therapy Technologies
1.1 Cell Therapy Technologies Market Overview
1.1.1 Cell Therapy Technologies Product Scope
1.1.2 Cell Therapy Technologies Market Status and Outlook
1.2 Global Cell Therapy Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell Therapy Technologies Market Size by Region (2018-2029)
1.4 Global Cell Therapy Technologies Historic Market Size by Region (2018-2023)
1.5 Global Cell Therapy Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell Therapy Technologies Market Size (2018-2029)
1.6.1 North America Cell Therapy Technologies Market Size (2018-2029)
1.6.2 Europe Cell Therapy Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Cell Therapy Technologies Market Size (2018-2029)
1.6.4 Latin America Cell Therapy Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Cell Therapy Technologies Market Size (2018-2029)
2 Cell Therapy Technologies Market by Type
2.1 Introduction
2.1.1 Equipment
2.1.2 Consumables
2.1.3 Others
2.2 Global Cell Therapy Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell Therapy Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Therapy Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Therapy Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell Therapy Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell Therapy Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell Therapy Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell Therapy Technologies Revenue Breakdown by Type (2018-2029)
3 Cell Therapy Technologies Market Overview by Application
3.1 Introduction
3.1.1 Human
3.1.2 Animal
3.2 Global Cell Therapy Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell Therapy Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Therapy Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Therapy Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell Therapy Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell Therapy Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell Therapy Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell Therapy Technologies Revenue Breakdown by Application (2018-2029)
4 Cell Therapy Technologies Competition Analysis by Players
4.1 Global Cell Therapy Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Therapy Technologies as of 2022)
4.3 Date of Key Players Enter into Cell Therapy Technologies Market
4.4 Global Top Players Cell Therapy Technologies Headquarters and Area Served
4.5 Key Players Cell Therapy Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Therapy Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Danaher
5.1.1 Danaher Profile
5.1.2 Danaher Main Business
5.1.3 Danaher Cell Therapy Technologies Products, Services and Solutions
5.1.4 Danaher Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Danaher Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Cell Therapy Technologies Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Cell Therapy Technologies Products, Services and Solutions
5.3.4 Merck Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Terumo Recent Developments
5.4 Terumo
5.4.1 Terumo Profile
5.4.2 Terumo Main Business
5.4.3 Terumo Cell Therapy Technologies Products, Services and Solutions
5.4.4 Terumo Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Terumo Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Cell Therapy Technologies Products, Services and Solutions
5.5.4 BD Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Lonza Group
5.6.1 Lonza Group Profile
5.6.2 Lonza Group Main Business
5.6.3 Lonza Group Cell Therapy Technologies Products, Services and Solutions
5.6.4 Lonza Group Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Group Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Cell Therapy Technologies Products, Services and Solutions
5.7.4 GE Healthcare Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Sartorius
5.8.1 Sartorius Profile
5.8.2 Sartorius Main Business
5.8.3 Sartorius Cell Therapy Technologies Products, Services and Solutions
5.8.4 Sartorius Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 Sartorius Recent Developments
5.9 Stemcell Technologies
5.9.1 Stemcell Technologies Profile
5.9.2 Stemcell Technologies Main Business
5.9.3 Stemcell Technologies Cell Therapy Technologies Products, Services and Solutions
5.9.4 Stemcell Technologies Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Stemcell Technologies Recent Developments
5.10 Miltenyi Biotec
5.10.1 Miltenyi Biotec Profile
5.10.2 Miltenyi Biotec Main Business
5.10.3 Miltenyi Biotec Cell Therapy Technologies Products, Services and Solutions
5.10.4 Miltenyi Biotec Cell Therapy Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Miltenyi Biotec Recent Developments
6 North America
6.1 North America Cell Therapy Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell Therapy Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Therapy Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Therapy Technologies Market Dynamics
11.1 Cell Therapy Technologies Industry Trends
11.2 Cell Therapy Technologies Market Drivers
11.3 Cell Therapy Technologies Market Challenges
11.4 Cell Therapy Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock